Eastern Bank Abbott Laboratories Transaction History

Eastern Bank

$5.25 Billion
Q4 2024

A detailed history of Eastern Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Eastern Bank holds 78,695 shares of ABT stock, worth $9.19 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

78,695

Previous 80,161 1.83%

Holding current value

$9.19 Million

Previous $9.14 Million 2.6%

% of portfolio

0.17%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$111.93 - $119.39 $164,089 - $175,025	-1,466 Reduced 1.83%	78,695 $8.9 Million
Q3 2024 Oct 21, 2024	BUY	$100.07 - $118.13 $4.83 Million - $5.71 Million	48,300 Added 151.6%	80,161 $9.14 Million
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $132,258 - $147,633	-1,313 Reduced 3.96%	31,861 $3.31 Million
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $599,950 - $662,618	-5,478 Reduced 14.17%	33,174 $3.77 Million
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $390,071 - $477,480	-4,325 Reduced 10.06%	38,652 $4.25 Million
Q3 2023 Oct 17, 2023	SELL	$95.53 - $114.62 $14.2 Million - $17 Million	-148,625 Reduced 77.57%	42,977 $4.16 Million
Q2 2023 Jul 19, 2023	SELL	$100.78 - $112.29 $844,133 - $940,541	-8,376 Reduced 4.19%	191,602 $20.9 Million
Q1 2023 Apr 19, 2023	BUY	$96.86 - $114.01 $2.54 Million - $2.99 Million	26,257 Added 15.11%	199,978 $20.2 Million
Q4 2022 Jan 24, 2023	SELL	$95.06 - $111.52 $33,746 - $39,589	-355 Reduced 0.2%	173,721 $0
Q3 2022 Oct 19, 2022	SELL	$96.76 - $112.03 $625,553 - $724,273	-6,465 Reduced 3.58%	174,076 $16.8 Million
Q2 2022 Jul 20, 2022	SELL	$102.07 - $123.37 $832,074 - $1.01 Million	-8,152 Reduced 4.32%	180,541 $19.6 Million
Q1 2022 Apr 21, 2022	SELL	$114.02 - $139.04 $2.61 Million - $3.18 Million	-22,878 Reduced 10.81%	188,693 $22.3 Million
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $322,097 - $394,390	2,788 Added 1.34%	211,571 $29.8 Million
Q3 2021 Oct 19, 2021	BUY	$116.66 - $129.06 $357,096 - $395,052	3,061 Added 1.49%	208,783 $24.7 Million
Q2 2021 Jul 20, 2021	BUY	$105.79 - $124.53 $228,929 - $269,482	2,164 Added 1.06%	205,722 $23.9 Million
Q1 2021 Apr 27, 2021	SELL	$108.84 - $128.23 $2.54 Million - $2.99 Million	-23,296 Reduced 10.27%	203,558 $24.4 Million
Q4 2020 Jan 20, 2021	BUY	$105.0 - $114.42 $147,525 - $160,760	1,405 Added 0.62%	226,854 $24.8 Million
Q3 2020 Oct 30, 2020	BUY	$91.64 - $111.29 $1.56 Million - $1.9 Million	17,054 Added 8.18%	225,449 $24.5 Million
Q2 2020 Jul 21, 2020	SELL	$76.57 - $98.0 $388,056 - $496,664	-5,068 Reduced 2.37%	208,395 $19.1 Million
Q1 2020 Apr 27, 2020	BUY	$62.82 - $91.86 $386,343 - $564,939	6,150 Added 2.97%	213,463 $16.8 Million
Q4 2019 Feb 04, 2020	BUY	$78.51 - $87.4 $488,489 - $543,802	6,222 Added 3.09%	207,313 $18 Million
Q3 2019 Nov 04, 2019	BUY	$81.84 - $88.74 $248,629 - $269,592	3,038 Added 1.53%	201,091 $16.8 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $3.42 Million - $3.99 Million	-46,985 Reduced 19.17%	198,053 $16.7 Million
Q1 2019 Apr 18, 2019	BUY	$66.22 - $80.06 $286,070 - $345,859	4,320 Added 1.79%	245,038 $19.6 Million
Q4 2018 Jan 18, 2019	BUY	$65.56 - $74.27 $107,846 - $122,174	1,645 Added 0.69%	240,718 $17.4 Million
Q3 2018 Oct 16, 2018	BUY	$60.81 - $73.36 $203,531 - $245,535	3,347 Added 1.42%	239,073 $17.5 Million
Q2 2018 Jul 18, 2018	BUY	$57.57 - $63.54 $522,620 - $576,816	9,078 Added 4.01%	235,726 $14.4 Million
Q1 2018 Apr 09, 2018	BUY	$56.27 - $63.62 $11.8 Million - $13.4 Million	210,397 Added 1294.67%	226,648 $13.6 Million
Q4 2017 Jan 22, 2018	SELL	$53.68 - $57.47 $23,189 - $24,827	-432 Reduced 2.59%	16,251 $928,000
Q3 2017 Oct 24, 2017	BUY	$48.06 - $53.64 $801,784 - $894,876	16,683	16,683 $890,000

Others Institutions Holding ABT

# of Institutions

3,198

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastern Bank, based on Form 13F filings with the SEC.

News

Stay updated on Eastern Bank with notifications on news.

Account